Lymphedema affects up to 250 million people worldwide. The understanding of the
pathophysiology of the condition, however, is incomplete and a cure remains elusive. A …

Secondary lymphedema of the upper and lower extremities related to prior oncologic
therapies, including cancer surgeries, radiation therapy, and chemotherapy, is a major …

Lymphedema results from lymphatic insufficiency leading to a progressive inflammatory
process that ultimately manifests as discomfort, recurrent infections, and, at times, secondary …

Advances in our understanding of the lymphatic system and the pathogenesis of
lymphedema have resulted in the development of effective surgical treatments. Vascularized …

Lymphedema often is confused with other causes of extremity edema and enlargement.
Understanding the risk factors and physical examination signs of lymphedema can enable …

Breast cancer-related lymphedema (BCRL) represents a global healthcare issue affecting
the emotional and life quality of breast cancer survivors significantly. The clinical …

Background There is no consensus on the appropriate treatment of lymphedema. Proposed
techniques include lymphaticovenous anastomosis (LVA), vascularized lymph nodes …

Background Lymphedema is a chronic and debilitating condition that affects many cancer
survivors. Patient-reported outcome measures (PROMs) can give valuable insight into the …

Background: Lymphedema is the chronic enlargement of tissue due to inadequate lymphatic
function. Diagnosis is made by history and physical examination and confirmed with …

Background The pathophysiology of lymphoedema is poorly understood. Current treatment
options include compression therapy, resection, liposuction and lymphatic microsurgery, but …